Commodore Capital Lp - Significant Ownership

Signature - Title
Michael Kramarz - Managing Partner
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Commodore Capital Lp.

Significant Ownership of Commodore Capital Lp

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ELVN Enliven Therapeutics, Inc. Common Stock, par value $0.001 per share 9.9% $125M 6.02M Commodore Capital LP Jun 30, 2025
ASMB ASSEMBLY BIOSCIENCES, INC. Common Stock, par value $0.001 9.9% $41.2M 1.62M Commodore Capital LP Aug 8, 2025
SABS SAB BIOTHERAPEUTICS, INC. Common Stock, $0.0001 par value per share 9.9% $9.59M 4.52M Commodore Capital LP Sep 26, 2025
PALI PALISADE BIO, INC. Common Stock, par value $0.01 per share 9.9% $5.62M 9.69M Commodore Capital LP Oct 1, 2025
RLAY Relay Therapeutics, Inc. Common Stock, par value $0.0001 per share 7.8% $47.1M $11.8M 13.4M +33.5% Commodore Capital LP Jun 30, 2025
DRUG Bright Minds Biosciences Inc. Common Shares, without par value 7.2% $18M 500K COMMODORE CAPITAL LP Dec 31, 2024
COGT Cogent Biosciences, Inc. Common Stock, $0.001 Par Value 5.5% $77.4M $13.8M 6.41M +21.6% Commodore Capital LP Jul 7, 2025
CDTX Cidara Therapeutics, Inc. Common Stock, par value $0.0001 per share 5.5% $21.9M 1.18M Commodore Capital LP Jun 25, 2025
LB PHARMACEUTICALS INC Common Stock, $0.0001 par value per share 5.5% 1.23M Commodore Capital LP Sep 11, 2025
VRDN Viridian Therapeutics, Inc. Common Stock, $0.01 par value per share 5.3% $50.7M 4.3M Commodore Capital LP Apr 4, 2025
TERN Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 5.3% $13.5M 4.65M Commodore Capital LP Sep 9, 2025
TYRA Tyra Biosciences, Inc. Common Stock, $0.0001 par value per share 5.2% $21.9M 2.75M Commodore Capital LP May 7, 2025
NRIX Nurix Therapeutics, Inc. Common Stock, par value $0.001 per share 5.1% $45.7M 3.85M COMMODORE CAPITAL LP Feb 7, 2025
CLDX Celldex Therapeutics, Inc. Common Stock, par value $.001 5% $53.4M 3.35M COMMODORE CAPITAL LP Apr 3, 2025
MRUS Merus N.V. Common Shares, (euro) 0.09 nominal value per share 4.7% $237M -$15.1M 3.53M -6% Commodore Capital LP Jun 30, 2025
NGNE Neurogene Inc. Common Stock, $0.000001 par value 3% $8.06M 428K Commodore Capital LP Jun 30, 2025
CELC Celcuity Inc. Common Stock, $0.001 par value per share 2.9% $9M 1.1M COMMODORE CAPITAL LP Dec 31, 2024
NKTX Nkarta, Inc. Common Stock, $0.0001 par value per share 0.5% $549K 352K COMMODORE CAPITAL LP Dec 31, 2024
SLDB Solid Biosciences Inc. Common Stock $0.001 par value per share 0% $0 -$33.8M 0 -100% Commodore Capital LP Jun 30, 2025
CRDF Cardiff Oncology, Inc. Common Stock 0% $0 -$11.2M 0 -100% Commodore Capital LP Jun 30, 2025

Schedules 13D/G Reported by Commodore Capital Lp:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.